glp 3 retatrutide GLP-3 RT (LY3437943) Peptide GLP-3 Retatrutide (24mg vials) -
Description
What Causes Gastroparesis
Patient assistance programs could be more or less generous than current Eli Lilly programs
The most common adverse effects were nausea, vomiting, and diarrhea during the first 4-8 weeks of treatment
Thats especially true with weekly GLP1 injections, where timing affects how the medication builds up and tapers off throughout the week
